Development, maintenance and disruption of the blood-brain barrier
Open accessAbstract
The interface between the blood circulation and the neural tissue features unique characteristics that are encompassed by the term 'blood-brain barrier' (BBB). The main functions of this barrier, namely maintenance of brain homeostasis, regulation of influx and efflux transport, and protection from harm, are determined by its specialized multicellular structure. Every constituent cell type makes an indispensable contribution to the BBB's integrity. But if one member of the BBB fails, and as a result the barrier breaks down, there can be dramatic consequences and neuroinflammation and neurodegeneration can occur. In this Review, we highlight recently gained mechanistic insights into the development and maintenance of the BBB. We then discuss how BBB disruption can cause or contribute to neurological disease. Finally, we examine how this knowledge can be used to explore new possibilities for BBB repair.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The breakdown of the BBB is mainly due to the disruption of TJs, such as claudin-5.
“The breakdown of the BBB is mainly due to the disruption of TJs, such as claudin-5 [42, 43].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [43]
The “Links between the BBB and disease” section says BBB breakdown can involve disrupted tight junctions, and its ischemic-stroke subsection associates reduced claudin-5 expression with increased BBB permeability. But the review also identifies impaired transport processes and says the mechanisms of breakdown are manifold; it does not establish that tight-junction disruption is the main cause. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThe blood-brain barrier prevents the transfer of most small-molecule drugs and macromolecules into the brain.
“it prevents the transfer of most of small-molecule drugs and macromolecules (e.g., peptides, gene drugs, and protein drugs) into the brain (1–6).”
From Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection (2020) · cites this paper as [4]
The Introduction says the BBB’s tight junctions and low transcytosis greatly limit movement of molecules into the brain. It does not specifically establish that most small-molecule drugs or macromolecular drugs, including the examples in the citing sentence, are prevented from entering. (LLM, conf=0.82)
Experimental — accuracy not yet measuredTogether with microglia, astrocytes constitute the principal defensive system of the CNS and respond to damage-related stimuli including Aβ and glutamate overload in a process known as astrocyte reactivity.
“Together with microglia, astrocytes constitute the principal defensive system of the CNS [37], responding to numerous damage‐related stimuli [6, 7, 8, 9] including amyloid β peptides (Aβ) and glutamate overload, in a process known as astrocyte reactivity [15, 37, 38, 39, 40].”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: <scp><i>APOE3</i></scp> Christchurch homozygote glioprotection (2023) · cites this paper as [7]
The section ‘The role of astrocytes in BBB regulation’ says astrocytes control immune reactions, and ‘BBB compromise in chronic neurodegeneration: ALS’ reports that microglia and astrocytes become activated after tissue injury. These passages support a defensive role and an activation response, but do not call the two cell types the CNS’s principal defensive system or identify the response as ‘astrocyte reactivity.’ The cited paper also does not substantiate Aβ or glutamate overload as triggers in this account. (LLM, conf=0.82)
Experimental — accuracy not yet measuredAstrocyte reactivity has frequently been associated with neuroinflammation, unfavorable glial scar formation, glutamate dyshomeostasis, altered coverage of synapses and blood vessels, and BBB breakout.
“Hence, astrocyte reactivity has frequently been associated with neuroinflammation, unfavorable glial scar formation [7, 8, 9, 37, 38, 43, 48, 49], glutamate dyshomeostasis [43, 50, 51], altered coverage of synapses and blood vessels, and BBB breakout [38, 42, 43, 45, 46, 47].”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: <scp><i>APOE3</i></scp> Christchurch homozygote glioprotection (2023) · cites this paper as [7]
The sections on epilepsy and ALS link astrocytic inflammatory activity with increased BBB permeability and describe reduced astrocyte glutamate transport and swollen perivascular end-feet. They do not establish the full claimed association of astrocyte reactivity with unfavorable glial scars or altered synaptic coverage, and the BBB findings are presented in specific disease contexts rather than as a general consequence of reactivity. (LLM, conf=0.85)
Experimental — accuracy not yet measuredTreatment with glucocorticoids offers blood-brain barrier protection.
“Treatment with glucocorticoids also offers BBB protection (446).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [446]
Treatment of central nervous system diseases is severely constrained by the blood-brain barrier.
“The treatment of central nervous system (CNS) diseases, such as neurodegenerative disorders, brain tumors, brain infections, and stroke, is severely constrained by the blood-brain barrier (BBB) because it prevents the transfer of most of small-molecule drugs and macromolecules (e.g., peptides, gene drugs, and protein drugs) into the brain (1–6).”
From Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection (2020) · cites this paper as [4]
Astrocytic processes surround most of the vascular surface and regulate blood-brain barrier permeability by modulating tight junction proteins such as claudin-5 and endothelial proteins such as vimentin.
“Astrocytic processes surround most of the vascular surface, regulating the blood–brain barrier (BBB) permeability [6, 7, 8, 9]—by modulating tight junction proteins such as claudin‐5 [10], or endothelial proteins such vimentin, which is associated with the stability of cerebral vasculature [11]—and integrate neuronal activity with blood flow [1, 2, 3, 4, 5, 12, 13, 14, 15, 16, 17, 18, 19, 20].”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: <scp><i>APOE3</i></scp> Christchurch homozygote glioprotection (2023) · cites this paper as [7]
The third shared process, geneM26/isoM22, is downregulated and enriched for endothelial and pericyte genes, with hubs including blood-brain barrier markers ITIH5, SLC38A5, ABCB1, and GPR124.
“The third biological process, geneM26/isoM22 (Fig 5C), is downregulated, and enriched for endothelial and pericyte genes, with hubs that represent markers of the blood-brain barrier, including ITIH5, SLC38A5, ABCB1, and GPR124, a critical regulator of brain-specific angiogenesis (53, 54).”
From Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder (2018) · cites this paper as [54]
The third shared process, geneM26/isoM22, is downregulated and enriched for endothelial and pericyte genes, with hubs including blood-brain barrier markers ITIH5, SLC38A5, ABCB1, and GPR124.
“The third biological process, geneM26/isoM22 (Fig 5C), is downregulated, and enriched for endothelial and pericyte genes, with hubs that represent markers of the blood-brain barrier, including ITIH5, SLC38A5, ABCB1, and GPR124, a critical regulator of brain-specific angiogenesis (53, 54).”
From Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder (2018) · cites this paper as [53]
The brain inflammatory response to antigen infiltration triggered by activated microglia may result in aberrant expression of several chemokines, leading to alterations in BBB permeability.
“the brain inflammatory response to antigen infiltration (virus, bacteria or fungus) triggered by activated microglia may result in aberrant expression of several chemokines, leading to alterations in BBB permeability (Buckner et al., 2006; Obermeier et al., 2013).”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Obermeier et al., 2013
Neuroinflammation is a key component of cell death cascades in stroke, with microglial cells and peripheral leukocytes, especially neutrophils and monocytes/macrophages, as main players.
“One of the key components of the cell death cascades in stroke is neuroinflammation, where the main players are microglial cells and the peripheral leukocytes, especially neutrophils and monocytes/macrophages.”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Obermeier et al., 2013
MMPs are further stimulated by NK-κB and HIF-1α and disrupt tight junction proteins (ZO-1, claudin-5 and occludin), rendering the BBB leaky; these downstream effects are reverted by blocking NOS.
“MMPs are further stimulated by NK-κB and HIF-1α and disrupt TJ proteins (as ZO-1, claudin-5 and occludin), rendering the BBB leaky, downstream effects which were shown to be reverted by blocking NOS (Yang and Rosenberg, 2011; Gu et al., 2012; Obermeier et al., 2013).”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Obermeier et al., 2013
The early opening (12-48 h) of the BBB is mainly caused by oxidative stress, with ROS as the most important mediator.
“The early opening (12–48 h) of the BBB is mainly caused by oxidative stress, being ROS the most important mediator.”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Obermeier et al., 2013
In the early phase, release of cytokine pools trapped by BBB ECM (molecule trapping) activates glial and endothelial cells and contributes to recruitment of peripheral immune cells.
“Another phenomenon observed in this early phase is the release of cytokine pools that were trapped by BBB ECM (“molecule trapping”), that activate glial and ECs and contribute to the recruitment of peripheral immune cells (Obermeier et al., 2013).”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Obermeier et al., 2013
ROS activate latent MMP-2 minutes after ischemic insult and are produced by microglia and astrocytes through the HIF-1α pathway.
“They activate the latent MMP-2 min after the ischemic insult, and are produced by microglia and astrocytes through the HIF-1α pathway (Yang and Rosenberg, 2011; Obermeier et al., 2013).”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Obermeier et al., 2013
Brain vascular endothelial cells connect with each other through junction proteins and are enveloped by surrounding pericytes and astrocytes to form the blood-brain barrier.
“Brain vascular endothelial cells (ECs) connect with each other through junction proteins and are enveloped by surrounding pericytes and astrocytes to form the blood-brain barrier (BBB)1,2,3,4.”
From Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity (2017) · cites this paper as [4]
The blood-brain barrier restricts material exchange between the brain and blood vessels to maintain homeostasis of the brain microenvironment.
“The BBB restricts material exchange between the brain and blood vessels to maintain the homeostasis of the brain microenvironment, which is crucial for the normal development and function of the central nervous system (CNS)1,2,3,4.”
From Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity (2017) · cites this paper as [4]
Wnt and Sonic Hedgehog pathways were found to be implicated in neural regulation of brain vasculature.
“several signaling pathways, in particular the Wnt and Sonic Hedgehog (Shh) pathways, were found to be implicated in this neural regulation4,5.”
From Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity (2017) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · see citing works
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595 · see citing works
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325 · see citing works
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,114 · see citing works
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931 · see citing works
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239 · see citing works
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · see citing works
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122 · see citing works
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · see citing works
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843 · see citing works
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653 · see citing works
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288 · see citing works
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257 · see citing works
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226 · see citing works
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182 · see citing works
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128 · see citing works
Self-citationRowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,851 · see citing works
Phenotypic Heterogeneity of the Endothelium
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,744 · see citing works
Hellström, M., Kalén, M., Lindahl, P., Abramsson, A., & Betsholtz, C. (1999) · Development · doi:10.1242/dev.126.14.3047 · Cited by 1,702 · see citing works
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448 · see citing works
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293 · see citing works
Phenotypic Heterogeneity of the Endothelium
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255690.03436.ae · Cited by 1,252 · see citing works
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.
Lucchinetti, C., Mandler, R., McGavern, D., Brück, W., Gleich, G., Ransohoff, R., Trebst, C., Weinshenker, B., Wingerchuk, D., Parisi, J., et al. (2002) · Brain : a journal of neurology · doi:10.1093/brain/awf151 · Cited by 1,228 · see citing works
Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis
Hellström, M., Gerhardt, H., Kalén, M., Li, X., Eriksson, U., Wolburg, H., & Betsholtz, C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.3.543 · Cited by 1,103 · see citing works
Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features
Bartynski, W. S. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0928 · Cited by 1,100 · see citing works
In Search of the In Vivo Identity of Mesenchymal Stem Cells
da Silva Meirelles, L., Caplan, A. I., & Nardi, N. B. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1122 · Cited by 1,077 · see citing works
The anatomical and cellular basis of immune surveillance in the central nervous system
Ransohoff, R. M., & Engelhardt, B. (2012) · Nature reviews. Immunology · doi:10.1038/nri3265 · Cited by 975 · see citing works
Self-citationCentral nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962 · see citing works
Potassium buffering in the central nervous system
Kofuji, P., & Newman, E. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.008 · Cited by 847 · see citing works
The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
Alvarez, J. I., Dodelet-Devillers, A., Kebir, H., Ifergan, I., Fabre, P. J., Terouz, S., Sabbagh, M., Wosik, K., Bourbonnière, L., Bernard, M., et al. (2011) · Science · doi:10.1126/science.1206936 · Cited by 845 · see citing works
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Akhmetshina, A., Palumbo, K., Dees, C., Bergmann, C., Venalis, P., Zerr, P., Horn, A., Kireva, T., Beyer, C., Zwerina, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms1734 · Cited by 843 · see citing works
Pöschl, E., Schlötzer-Schrehardt, U. M., Brachvogel, B., Saito, K., Ninomiya, Y., & Mayer, U. (2004) · Development · doi:10.1242/dev.01037 · Cited by 816 · see citing works
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800 · see citing works
Oxidative Stress as a Regulator of Gene Expression in the Vasculature
KUNSCH, C. A., & Medford, R. M. (1999) · Circulation Research · doi:10.1161/01.res.85.8.753 · Cited by 795 · see citing works
Wnt/β-catenin signaling controls development of the blood–brain barrier
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C. J., Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806024 · Cited by 793 · see citing works
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · see citing works
The blood–brain barrier in health and disease
Daneman, R. (2012) · Annals of Neurology · doi:10.1002/ana.23648 · Cited by 756 · see citing works
Self-citationWnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis
Daneman, R., Agalliu, D., Zhou, L., Kuhnert, F., Kuo, C. J., & Barres, B. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805165106 · Cited by 753 · see citing works
Self-citationAstrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease
Argaw, A. T., Asp, L., Zhang, J., Navrazhina, K., Pham, T., Mariani, J. N., Mahase, S., Dutta, D. J., Seto, J., Kramer, E. G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60842 · Cited by 733 · see citing works
Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Brück, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716 · see citing works
Ravizza, T., Gagliardi, B., Noè, F. M., Boer, K., Aronica, E., & Vezzani, A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.08.012 · Cited by 700 · see citing works
Capture, crawl, cross: the T cell code to breach the blood–brain barriers
Engelhardt, B., & Ransohoff, R. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.004 · Cited by 686 · see citing works
Self-citationStewart, P. A., & Wiley, M. J. (1981) · Developmental Biology · doi:10.1016/0012-1606(81)90382-1 · Cited by 684 · see citing works
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wallPreprint
Lindblom, P., Gerhardt, H., Liebner, S., Abramsson, A., Enge, M., Hellström, M., Bäckström, G., Fredriksson, S., Landegren, U. D., Nyström, H. C., et al. (2003) · Genes & Development · doi:10.1101/gad.266803 · Cited by 659 · see citing works
Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury
Chodobski, A., Zink, B. J., & Szmydynger‐Chodobska, J. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0125-x · Cited by 655 · see citing works
An open label study of the effects of rituximab in neuromyelitis optica
Cree, B., Lamb, S., Morgan, K., Chen, A., Waubant, E. L., & Genain, C. P. (2005) · Neurology · doi:10.1212/01.wnl.0000159399.81861.d5 · Cited by 646 · see citing works
Canonical Wnt Signaling Regulates Organ-Specific Assembly and Differentiation of CNS Vasculature
Stenman, J. M., Rajagopal, J., Carroll, T. J., Ishibashi, M., McMahon, J., & McMahon, A. P. (2008) · Science · doi:10.1126/science.1164594 · Cited by 641 · see citing works
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633 · see citing works
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 613 · see citing works
Gilden, D., Cohrs, R. J., Mahalingam, R., & Nagel, M. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70134-6 · Cited by 613 · see citing works
Pola, R., Ling, L. E., Silver, M., Corbley, M. J., Kearney, M., Pepinsky, R. B., Shapiro, R. I., Taylor, F. R., Baker, D. P., Asahara, T., et al. (2001) · Nature Medicine · doi:10.1038/89083 · Cited by 610 · see citing works
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
Bradl, M., Misu, T., Takahashi, T., Watanabe, M., Mader, S., Reindl, M., Adzemovic, M. Z., Bauer, J., Berger, T., Fujihara, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21837 · Cited by 582 · see citing works
Daneman, R., Zhou, L., Agalliu, D., Cahoy, J. D., Kaushal, A., & Barres, B. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013741 · Cited by 577 · see citing works
Self-citationEngaging neuroscience to advance translational research in brain barrier biology
Neuwelt, E. A., Bauer, B., Fahlke, C. M., Fricker, G., Iadecola, C., Janigro, D., Leybaert, L., Molnár, Z., O’Donnell, M. E., Povlishock, J. T., et al. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn2995 · Cited by 577 · see citing works
Expression and Function of Laminins in the Embryonic and Mature Vasculature
Hallmann, R., Horn, N., Selg, M., Wendler, O., Pausch, F., & Sorokin, L. M. (2005) · Physiological Reviews · doi:10.1152/physrev.00014.2004 · Cited by 575 · see citing works
Saadoun, S., Waters, P., Bell, B., Vincent, A., Verkman, A., & Papadopoulos, M. (2010) · Brain : a journal of neurology · doi:10.1093/brain/awp309 · Cited by 574 · see citing works
TGF- receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis
Ivens, S., Kaufer, D., Flores, L. P., Bechmann, I., Zumsteg, D., Tomkins, O., Seiffert, E., Heinemann, U., & Friedman, A. (2007) · Brain · doi:10.1093/brain/awl317 · Cited by 567 · see citing works
Montaner, J., Molina, C. A., Monasterio, J., Abilleira, S., Arenillas, J. F., Ribó, M., Quintana, M., & Álvarez‐Sabín, J. (2003) · Circulation · doi:10.1161/01.cir.0000046451.38849.90 · Cited by 557 · see citing works
A role for leukocyte-endothelial adhesion mechanisms in epilepsy
Fabene, P. F., Mora, G. N., Martinello, M., Rossi, B., Merigo, F., Ottoboni, L., Bach, S., Angiari, S., Benati, D., Chakir, A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1878 · Cited by 509 · see citing works
Seizure‐Promoting Effect of Blood–Brain Barrier Disruption
Marchi, N., Angelov, L., Masaryk, T., Fazio, V. J., Granata, T., Hernandez, N., Hallene, K. L., Diglaw, T., Franic, L. A., Najm, I., et al. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00988.x · Cited by 508 · see citing works
REGULATION OF PROTEIN FUNCTION BY GLYCOSAMINOGLYCANS—AS EXEMPLIFIED BY CHEMOKINES
Handel, T. M., Johnson, Z., Crown, S. E., Lau, E. K., Sweeney, M., & Proudfoot, A. E. I. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161747 · Cited by 506 · see citing works
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Hinson, S. R., Pittock, S., Lucchinetti, C., Roemer, S., Fryer, J., Kryzer, T. J., & Lennon, V. (2007) · Neurology · doi:10.1212/01.wnl.0000289761.64862.ce · Cited by 482 · see citing works
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration
Zhong, Z., Deane, R., Ali, Z., Parisi, M., Shapovalov, Y., O'Banion, M. K., Stojanovic, K., Sagare, A., Boillee, S., Cleveland, D. W., et al. (2008) · Nature Neuroscience · doi:10.1038/nn2073 · Cited by 476 · see citing works
SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier
Lee, S., Kim, W. J., Choi, Y. K., Song, H. S., Son, M. J., Gelman, I. H., Kim, Y.-J., & Kim, K. (2003) · Nature Medicine · doi:10.1038/nm889 · Cited by 473 · see citing works
Involvement of ROS in BBB dysfunction
Pun, P. B. L., Lu, J., & Moochhala, S. (2009) · Free Radical Research · doi:10.1080/10715760902751902 · Cited by 457 · see citing works
Pericytes: Cell Biology and Pathology
Allt, G., & Lawrenson, J. G. (2001) · Cells Tissues Organs · doi:10.1159/000047855 · Cited by 455 · see citing works
The role of shear stress in Blood-Brain Barrier endothelial physiology
Cucullo, L., Hossain, M., Puvenna, V., Marchi, N., & Janigro, D. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-40 · Cited by 437 · see citing works
Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications
Rapoport, S. I. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007049806660 · Cited by 428 · see citing works
Jiao, H., Wang, Z., Liu, Y., Wang, P., & Xue, Y. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9496-4 · Cited by 411 · see citing works
Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke
Baeten, K. M., & Akassoglou, K. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20954 · Cited by 397 · see citing works
Transcriptome Profiling Reveals TGF- Signaling Involvement in Epileptogenesis
Cacheaux, L. P., Ivens, S., David, Y. B., Lakhter, A. J., Bar‐Klein, G., Shapira, M., Heinemann, U., Friedman, A., & Kaufer, D. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0430-09.2009 · Cited by 385 · see citing works
Shawahna, R., Uchida, Y., Declèves, X., Ohtsuki, S., Yousif, S., Dauchy, S., Jacob, A., Chassoux, F., Daumas-Duport, C., Couraud, P.-O., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200129p · Cited by 372 · see citing works
Dohgu, S., Takata, F., Yamauchi, A., Nakagawa, S., Egawa, T., Naito, M., Tsuruo, T., Sawada, Y., Niwa, M., & Kataoka, Y. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.027 · Cited by 350 · see citing works
Haj‐Yasein, N. N., Vindedal, G. F., Eilert‐Olsen, M., Gundersen, G. A., Skare, Ø., Laake, P., Klungland, A., Thorén, A. E., Burkhardt, J. M., Ottersen, O. P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110655108 · Cited by 344 · see citing works
Hatherell, K. E., Couraud, P., Romero, I. A., Weksler, B. B., & Pilkington, G. J. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.05.012 · Cited by 334 · see citing works
Radical changes in multiple sclerosis pathogenesis
van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 322 · see citing works
Förster, C. Y., Burek, M., Romero, I. A., Weksler, B. B., Couraud, P., & Drenckhahn, D. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.146852 · Cited by 306 · see citing works
Essential Regulation of CNS Angiogenesis by the Orphan G Protein–Coupled Receptor GPR124
Kuhnert, F., Mancuso, M. R., Shamloo, A., Wang, H.-T., Choksi, V., Florek, M., Su, H., Fruttiger, M., Young, W. L., Heilshorn, S. C., et al. (2010) · Science · doi:10.1126/science.1196554 · Cited by 301 · see citing works
Reactive oxygen species and ischemic cerebrovascular disease
Olmez, I., & Özyurt, H. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.11.009 · Cited by 301 · see citing works
Zacharek, A., Chen, J., Li, A., Cui, X., Li, Y., Roberts, C., Feng, Y., Gao, Q., & Chopp, M. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600475 · Cited by 297 · see citing works
Astrocytic regulation of glutamate homeostasis in epilepsy
Coulter, D. A., & Eid, T. (2012) · Glia · doi:10.1002/glia.22341 · Cited by 292 · see citing works
Pericytes: Pluripotent Cells of the Blood Brain Barrier
Dore‐Duffy, P. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784705469 · Cited by 286 · see citing works
The disturbed blood–brain barrier in human glioblastoma
Wolburg, H., Noell, S., Fallier‐Becker, P., Mack, A. F., & Wolburg‐Buchholz, K. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.02.003 · Cited by 276 · see citing works
Nishitsuji, K., Hosono, T., Nakamura, T., Bu, G., & Michikawa, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225532 · Cited by 275 · see citing works
Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling
Haigh, J. J., Morelli, P. I., Gerhardt, H., Haigh, K., Tsien, J., Damert, A., Miquerol, L., Mühlner, U., Klein, R., Ferrara, N., et al. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00356-7 · Cited by 271 · see citing works
Suzuki, R., Yamaguchi, T., Kirino, T., Orzi, F., & KLATZO, I. (1983) · Acta Neuropathologica · doi:10.1007/bf00691868 · Cited by 269 · see citing works
β8 integrins are required for vascular morphogenesis in mouse embryos
Zhu, J., Motejlek, K., Wang, D., Zang, K., Schmidt, A., & Reichardt, L. F. (2002) · Development · doi:10.1242/dev.129.12.2891 · Cited by 267 · see citing works
Neurovascular Unit: a Focus on Pericytes
Sá-Pereira, I., Brites, D. M. T. O., & Brito, M. A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8244-2 · Cited by 267 · see citing works
Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
Kinoshita, M., Nakatsuji, Y., Kimura, T., Moriya, M., Takata, K., Okuno, T., Kumanogoh, A., Kajiyama, K., Yoshikawa, H., & Sakoda, S. (2009) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2009.06.085 · Cited by 262 · see citing works
Li, F., Lan, Y., Wang, Y., Wang, J., Yang, G., Meng, F., Han, H., Meng, A., Wang, Y., & Yang, X. Y. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.01.011 · Cited by 259 · see citing works
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R. A., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259 · see citing works
Bartels, A. L., Willemsen, A., Kortekaas, R., de Jong, B. M., de Vries, R., de Klerk, O., van Oostrom, J. C. H., Portman, A. T., & Leenders, K. L. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0030-y · Cited by 258 · see citing works
Blood‐brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy
Heinemann, U., Kaufer, D., & Friedman, A. (2012) · Glia · doi:10.1002/glia.22311 · Cited by 255 · see citing works
The Blood Brain Barrier in Neurodegenerative Disease: A Rhetorical Perspective
Carvey, P., Hendey, B., & Monahan, A. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06319.x · Cited by 254 · see citing works
Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage
Librizzi, L., Noè, F., Vezzani, A., de Curtis, M., & Ravizza, T. (2012) · Annals of Neurology · doi:10.1002/ana.23567 · Cited by 253 · see citing works
Igarashi, Y., Utsumi, H., Chiba, H., Yamada-Sasamori, Y., Tobioka, H., Kamimura, Y., Furuuchi, K., Kokai, Y., Nakagawa, T., Mori, M., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0992 · Cited by 252 · see citing works
Gu, Y., Zheng, G., Xu, M., Li, Y., Chen, X., Zhu, W., Tong, Y., Chung, S. K., Liu, K. J., & Shen, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07542.x · Cited by 251 · see citing works
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011452 · Cited by 251 · see citing works
Garbuzova-Davis, S. N., Saporta, S., Haller, E. M., Kolomey, I., Bennett, S. P., Potter, H., & Sanberg, P. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001205 · Cited by 248 · see citing works
Vincent, T., Saikali, P., Cayrol, R., Roth, A. D., Bar‐Or, A., Prat, A., & Antel, J. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5730 · Cited by 241 · see citing works
Williams, K. C., Alvarez, X. A., & Lackner, A. A. (2001) · Glia · doi:10.1002/glia.1105 · Cited by 237 · see citing works
Sobue, K., Yamamoto, N., Yoneda, K., Hodgson, M. E., Yamashiro, K., Tsuruoka, N., Tsuda, T., Katsuya, H., Miura, Y., Asai, K., et al. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00079-6 · Cited by 236 · see citing works
Current concepts of blood-brain barrier development
Liebner, S., Czupalla, C. J., & Wolburg, H. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103224sl · Cited by 227 · see citing works
Enzmann, G., Mysiorek, C., Gorina, R., Cheng, Y.-J., Ghavampour, S., Hannocks, M.-J., Prinz, V., Dirnagl, U., Endres, M., Prinz, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1076-3 · Cited by 225 · see citing works
Shechter, R., & Schwartz, M. (2012) · The Journal of Pathology · doi:10.1002/path.4106 · Cited by 225 · see citing works
Urich, E., Lazic, S. E., Molnos, J., Wells, I., & Freskgård, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038149 · Cited by 220 · see citing works
Cullen, M., ElZarrad, M. K., Seaman, S., Zudaire, E., Stevens, J., Yang, M., Li, X., Chaudhary, A., Xu, L., Hilton, M. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017192108 · Cited by 204 · see citing works
Raab, S., Beck, H., Gaumann, A. K. A., Yüce, A., Gerber, H., Plate, K. H., Hammes, H., Ferrara, N., & Breier, G. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-09-0582 · Cited by 198 · see citing works
Protein Kinase C δ Mediates Cerebral Reperfusion InjuryIn Vivo
Bright, R., Raval, A. P., Dembner, J. M., Pérez‐Pinzón, M. A., Steinberg, G. K., Yenari, M. A., & Mochly‐Rosen, D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4474-03.2004 · Cited by 198 · see citing works
Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis
Miyazaki, K., Ohta, Y., Nagai, M., Morimoto, N., Kurata, T., Takehisa, Y., Ikeda, Y., Matsuura, T., & Abe, K. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22594 · Cited by 197 · see citing works
Cristante, E., McArthur, S., Mauro, C., Maggioli, E., Romero, I. A., Wylezinska, M., Couraud, P. O., Lopez-Tremoleda, J., Christian, H., Weksler, B. B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209362110 · Cited by 197 · see citing works
Additive Effects of PDGF Receptor β Signaling Pathways in Vascular Smooth Muscle Cell Development
Tallquist, M. D., French, W. J., & Soriano, P. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000052 · Cited by 192 · see citing works
Miller, D. H., Thompson, A. J., Morrissey, S., MacManus, D. G., Moore, S. G., Kendall, B. E., MOSELEY, I. F., & McDonald, W. I. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.6.450 · Cited by 188 · see citing works
Sumi, N., Nishioku, T., Takata, F., Matsumoto, J., Watanabe, T., Shuto, H., Yamauchi, A., Dohgu, S., & Kataoka, Y. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9446-7 · Cited by 179 · see citing works
Integrin αvβ8-Mediated Activation of Transforming Growth Factor-β by Perivascular Astrocytes
Cambier, S., Gline, S. E., Mu, D., Collins, R., Araya, J., Dolganov, G., Einheber, S., Boudreau, N. J., & Nishimura, S. L. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62497-2 · Cited by 178 · see citing works
Inflammation and neurovascular changes in amyotrophic lateral sclerosis
Evans, M. C., Couch, Y., Sibson, N. R., & Turner, M. R. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.008 · Cited by 176 · see citing works
Wnt family proteins are secreted and associated with the cell surface.
Smolich, B. D., McMahon, J. A., McMahon, A. P., & Papkoff, J. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.12.1267 · Cited by 172 · see citing works
Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat
Nicaise, C., Mitrecic, D., Demetter, P., De Decker, R., Authelet, M., Boom, A., & Pochet, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.018 · Cited by 168 · see citing works
Kostka, G., Giltay, R., Bloch, W., Addicks, K., Timpl, R., Fässler, R., & Chu, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.7025-7034.2001 · Cited by 168 · see citing works
McCarty, J. H., Monahan-Earley, R. A., Brown, L. F., Keller, M., Gerhardt, H., Rubin, K., Shani, M., Dvorak, H. F., Wolburg, H., Bader, B., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7667-7677.2002 · Cited by 166 · see citing works
Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0883-2 · Cited by 160 · see citing works
The biological relevance of chemokine–proteoglycan interactions
Proudfoot, A. E. I. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340422 · Cited by 159 · see citing works
Morin-Brureau, M., Lebrun, A., Rousset, M.-C., Fagni, L., Bockaert, J., de Bock, F., & Lerner-Natoli, M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5692-10.2011 · Cited by 159 · see citing works
Astrocytes: regulation of brain homeostasis via apolipoprotein E
Gee, J. R., & Keller, J. N. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.004 · Cited by 155 · see citing works
Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor
Anderson, K. D., Li, P., Yang, X., Hughes, V. C., Walls, J. R., Dominguez, M. G., Simmons, M. V., Burfeind, P., Xue, Y., Wei, Y., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019761108 · Cited by 153 · see citing works
Pillai, D. R., Dittmar, M. S., Baldaranov, D., Heidemann, R. M., Henning, E. C., Schuierer, G. R., Bogdahn, U., & Schlachetzki, F. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.106 · Cited by 152 · see citing works
Osada, T., Gu, Y.-H., Kanazawa, M., Tsubota, Y., Hawkins, B. T., Spatz, M., Milner, R., & del Zoppo, G. J. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.99 · Cited by 150 · see citing works
ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage
Hafezi-Moghadam, A., Thomas, K. L., & Wagner, D. D. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00563.2005 · Cited by 149 · see citing works
Phuan, P.-W., Ratelade, J., Rossi, A., Tradtrantip, L., & Verkman, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344325 · Cited by 146 · see citing works
Xue, Q., Liu, Y., Qi, H., Ma, Q., Xu, L., Chen, W., Chen, G., & Xu, X. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.5115 · Cited by 144 · see citing works
Neutrophil protein kinase Cδ as a mediator of stroke-reperfusion injury
Chou, W.-H., Choi, D., Zhang, H., Mu, D., McMahon, T., Kharazia, V., Lowell, C. A., Ferriero, D. M., & Messing, R. O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21655 · Cited by 144 · see citing works
Lyck, R., Ruderisch, N., Moll, A. G., Steiner, O., Cohen, C. D., Engelhardt, B., Makrides, V., & Verrey, F. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.72 · Cited by 140 · see citing works
Death Receptors DR6 and TROY Regulate Brain Vascular Development
Tam, S. J., Richmond, D., Kaminker, J. S., Modrusan, Z. D., Martin-McNulty, B., Cao, T. C., Weimer, R. M., Carano, R. A. D., van Bruggen, N., & Watts, R. J. (2012) · Developmental Cell · doi:10.1016/j.devcel.2011.11.018 · Cited by 138 · see citing works
Differentiation of the brain vasculature: the answer came blowing by the Wnt
Liebner, S., & Plate, K. H. (2010) · Vascular Cell · doi:10.1186/2040-2384-2-1 · Cited by 138 · see citing works
Dong, L., Chen, Y., Lewis, M. E., Hsieh, J.-C., Reing, J. E., Chaillet, J. R., Howell, C. Y., Melhem, M. F., Inoué, S., Kuszak, J. R., et al. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000042240.52093.0f · Cited by 132 · see citing works
Wang, J., & Milner, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03521.x · Cited by 129 · see citing works
Amyotrophic lateral sclerosis: A neurovascular disease
Garbuzova-Davis, S. N., Rodrigues, M. C. O., Hernandez‐Ontiveros, D. G., Louis, M. K., Willing, A. E., Borlongan, C. V., & Sanberg, P. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.049 · Cited by 128 · see citing works
Neurovascular Coupling in Cognitive Impairment Associated With Diabetes Mellitus
Mogi, M., & Horiuchi, M. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0121 · Cited by 128 · see citing works
Kim, S., Kim, W., Huh, S., Lee, K. Y., Jung, I. J., & Kim, H. J. (2013) · Journal of Clinical Neurology · doi:10.3988/jcn.2013.9.1.36 · Cited by 126 · see citing works
Developmental Regulation of β1 Integrins during Angiogenesis in the Central Nervous System
Milner, R. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1151 · Cited by 126 · see citing works
Initial Management of Epilepsy
French, J. A., & Pedley, T. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0801738 · Cited by 126 · see citing works
The role of the blood–CNS barrier in CNS disorders and their treatment
Palmer, A. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.029 · Cited by 118 · see citing works
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab
Kleinschmidt-DeMasters, B. K., Miravalle, A. A., Schowinsky, J. T., Corboy, J. R., & Vollmer, T. R. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825caf2c · Cited by 116 · see citing works
Janigro, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03472.x · Cited by 115 · see citing works
Oxidative stress in amyotrophic lateral sclerosis
Robberecht, W. (2000) · Journal of Neurology · doi:10.1007/s004150050551 · Cited by 112 · see citing works
Abbott, N. J., Dolman, D. E. M., Drndarski, S., & Fredriksson, S. M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-452-0_28 · Cited by 110 · see citing works
Cucullo, L., Hossain, M., Tierney, W. S., & Janigro, D. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-18 · Cited by 107 · see citing works
Modelling the Neurovascular Unit and the Blood-Brain Barrier with the Unique Function of Pericytes
Vandenhaute, E., Dehouck, L., Boucau, M., Sevin, E., Uzbekov, R. E., Tardivel, M., Gosselet, F., Fénart, L., Cecchelli, R., & Dehouck, M. (2011) · Current Neurovascular Research · doi:10.2174/156720211798121016 · Cited by 106 · see citing works
Cree, B., Goodin, D. S., & Hauser, S. L. (2002) · Seminars in Neurology · doi:10.1055/s-2002-36534 · Cited by 106 · see citing works
Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack
Davis, S. M., & Donnan, G. A. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1107281 · Cited by 105 · see citing works
Förster, C. Y., Kahles, T., Kietz, S., & Drenckhahn, D. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.129007 · Cited by 102 · see citing works
Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA.
Milsted, A., Barna, B. P., Ransohoff, R. M., Brosnihan, K. B., & Ferrario, C. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5720 · Cited by 102 · see citing works
Self-citationMicrovascular protection is essential for successful neuroprotection in stroke
Özdemir, Y., Yemişçi, M., & Dalkara, T. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07938.x · Cited by 102 · see citing works
Sera from neuromyelitis optica patients disrupt the blood–brain barrier
Shimizu, F., Sano, Y., Takahashi, T., Haruki, H., Saito, K., Koga, M., & Kanda, T. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300434 · Cited by 100 · see citing works
Primary angiitis of the central nervous system
Hajj‐Ali, R. A., & Calabrese, L. H. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.08.004 · Cited by 89 · see citing works
Man, S., Tucky, B. H., Cotleur, A. C., Drazba, J. A., Takeshita, Y., & Ransohoff, R. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003197 · Cited by 84 · see citing works
Self-citationNeurological autoimmunity targeting aquaporin-4
Hinson, S. R., McKeon, A. B., & Lennon, V. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.032 · Cited by 82 · see citing works
Migraine aura: new information on underlying mechanisms
del Río, M. S., & Reuter, U. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200406000-00009 · Cited by 75 · see citing works
Hedgehog signalling in vascular development
Nagase, T., Nagase, M., Machida, M., & Fujita, T. (2008) · Angiogenesis · doi:10.1007/s10456-008-9105-5 · Cited by 69 · see citing works
Blecharz, K., Haghikia, A., Stasiołek, M., Kruse, N., Drenckhahn, D., Gold, R., Roewer, N., Chan, A., & Förster, C. Y. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458509358189 · Cited by 66 · see citing works
Role of the vascular endothelium and plaque in acute ischemic stroke
Madden, J. A. (2012) · Neurology · doi:10.1212/wnl.0b013e3182695836 · Cited by 62 · see citing works
Leukocyte trafficking mechanisms in epilepsy
Fabene, P. F., Laudanna, C., & Constantin, G. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.12.009 · Cited by 61 · see citing works
Sun, D., Lytle, C. Y., & O’Donnell, M. E. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.6.c1829 · Cited by 58 · see citing works
The crossroads of neuroinflammation in infectious diseases: endothelial cells and astrocytes
Combes, V., Guillemin, G. J., Chan‐Ling, T., Hunt, N. H., & Grau, G. E. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2012.05.008 · Cited by 57 · see citing works
The Potential of Mesenchymal Stromal Cells as a Novel Cellular Therapy for Multiple Sclerosis
Auletta, J. J., Bartholomew, A. M., Maziarz, R. T., Deans, R., Miller, R. H., Lazarus, H. M., & Cohen, J. A. (2012) · Immunotherapy · doi:10.2217/imt.12.41 · Cited by 56 · see citing works
Tomizawa, Y., Yokoyama, K., Saiki, S., Takahashi, T., Matsuoka, J., & Hattori, N. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000427 · Cited by 54 · see citing works
Angiogenesis in primary central nervous system lymphoma (PCNSL)
Takeuchi, H., Matsuda, K., Kitai, R., Sato, K., & Kubota, T. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9363-x · Cited by 53 · see citing works
Hosokawa, T., Nakajima, H., Doi, Y., Sugino, M., Kimura, F., Hanafusa, T., & Takahashi, T. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.04.009 · Cited by 52 · see citing works
Novel models for assessing blood–brain barrier drug permeation
Geldenhuys, W. J., Allen, D. D., & Bloomquist, J. R. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.677433 · Cited by 47 · see citing works
Leptomeningeal cells modulate the neurite growth promoting properties of astrocytes in vitro
Ness, R., & David, S. (1997) · Glia · doi:10.1002/(sici)1098-1136(199701)19:1 · Cited by 46 · see citing works
Effects of EEG of the osmotic opening of the blood-brain barrier in rats
Fieschi, C., Lenzi, G., Zanette, E. M., Orzi, F., & Passero, S. G. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90143-5 · Cited by 45 · see citing works
Dolghih, E., & Jacobson, M. P. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3001922 · Cited by 42 · see citing works
Primary and Secondary Central Nervous System Vasculitis
Gowdie, P. J., Twilt, M., & Benseler, S. M. (2012) · Journal of Child Neurology · doi:10.1177/0883073812459352 · Cited by 41 · see citing works
Genetic mouse models to study blood–brain barrier development and function
Sohet, F., & Daneman, R. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-3 · Cited by 40 · see citing works
Self-citationLu, M., & Hu, G. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05650.x · Cited by 33 · see citing works
Effector Functions of Antiaquaporin‐4 Autoantibodies in Neuromyelitis Optica
Cayrol, R., Saikali, P., & Vincent, T. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04871.x · Cited by 25 · see citing works
Methods to Assess Pericyte-Endothelial Cell Interactions in a Coculture Model
Thanabalasundaram, G., El‐Gindi, J., Lischper, M., & Galla, H. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-938-3_19 · Cited by 22 · see citing works
Effect of Steroids on Brain Lipocortin Immunoreactivity
Go, K. G., Zuiderveen, F., Ley, L., Haar, J. G., Parente, L., Solito, E., & Molenaar, W. M. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9334-1_26 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,453 · see citing works
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906 · see citing works
“The integrity of BBB could be breached by the intrinsic properties of the pathogens.(232) Directed evolution and capsid engineering have been developed to engineer a number of BBB-crossing AAVs.”
BackgroundEstablishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670 · see citing works
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573 · see citing works
Self-citationRothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4106 · Cited by 1,559 · see citing works
Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Gandal, M. J., Zhang, P., Hadjimichael, E., Walker, R. L., Chen, C., Liu, S., Won, H., van Bakel, H., Varghese, M., Wang, Y., et al. (2018) · Science · doi:10.1126/science.aat8127 · Cited by 1,247 · see citing works
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035 · see citing works
Astrocyte Crosstalk in CNS Inflammation
Linnerbauer, M., Wheeler, M. A., & Quintana, F. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.012 · Cited by 989 · see citing works
Engineering of human brain organoids with a functional vascular-like system
Çakır, B., Xiang, Y., Tanaka, Y., Kural, M. H., Parent, M. J., Kang, Y., Chapeton, K., Patterson, B., Yuan, Y., He, C., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0586-5 · Cited by 959 · see citing works
Blood-brain barrier dysfunction and recovery after ischemic stroke
Jiang, X., Andjelkovic, A. V., Zhu, L., Yang, T., Bennett, M. V. L., Chen, J., Keep, R. F., & Shi, Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.001 · Cited by 946 · see citing works
Dual microglia effects on blood brain barrier permeability induced by systemic inflammation
Haruwaka, K., Ikegami, A., Tachibana, Y., Ohno, N., Konishi, H., Hashimoto, A., Matsumoto, M., Kato, D., Ono, R., Kiyama, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13812-z · Cited by 923 · see citing works
A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk
Yang, A. C., Vest, R. T., Kern, F., Lee, D. P., Agam, M., Maat, C. A., Losada, P. M., Chen, M. B., Schaum, N., Khoury, N., et al. (2022) · Nature · doi:10.1038/s41586-021-04369-3 · Cited by 797 · see citing works
Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology
Augustin, H. G., & Koh, G. Y. (2017) · Science · doi:10.1126/science.aal2379 · Cited by 762 · see citing works
The blood–brain barrier in health and disease: Important unanswered questions
Profaci, C. P., Munji, R. N., Pulido, R. S., & Daneman, R. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190062 · Cited by 777 · see citing works
Self-citationThe blood-brain barrier in aging and neurodegeneration
Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738 · see citing works
“The disruption mechanisms of oxidative stress include oxidative damage to cellular components (protein oxidation, lipid peroxidation, and DNA damage), activation of matrix metalloproteinases, cytoskeleton reorganization, modulation of tight junction proteins, and upregulation of inflammatory mediators [81, 86, 87].”
BackgroundThe biphasic function of microglia in ischemic stroke
Ma, Y., Wang, J., Wang, Y., & Yang, G. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.005 · Cited by 724 · see citing works
Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms
Huang, X., Hussain, B., & Chang, J. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13569 · Cited by 732 · see citing works
Campisi, M., Shin, Y., Osaki, T., Hajal, C., Chiono, V., & Kamm, R. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.014 · Cited by 718 · see citing works
Function and therapeutic value of astrocytes in neurological diseases
Lee, H.-G., Wheeler, M. A., & Quintana, F. J. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00390-x · Cited by 662 · see citing works
The role of peripheral immune cells in the CNS in steady state and disease
Prinz, M., & Priller, J. (2017) · Nature Neuroscience · doi:10.1038/nn.4475 · Cited by 657 · see citing works
The dynamic blood–brain barrier
Keaney, J., & Campbell, M. (2015) · The FEBS Journal · doi:10.1111/febs.13412 · Cited by 616 · see citing works
Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain
Yuan, D., Zhao, Y., Banks, W. A., Bullock, K. M., Haney, M., Batrakova, E., & Kabanov, A. V. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.011 · Cited by 607 · see citing works
Interaction of Microglia and Astrocytes in the Neurovascular Unit
Liu, L., Liu, J., Bao, J.-S., Bai, Q.-Q., & Wang, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01024 · Cited by 591 · see citing works
Claudin-5: gatekeeper of neurological function
Greene, C., Hanley, N., & Campbell, M. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0123-z · Cited by 583 · see citing works
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572 · see citing works
A combination of ontogeny and CNS environment establishes microglial identity
Bennett, F. C., Bennett, M. L., Yaqoob, F., Mulinyawe, S. B., Grant, G. A., Hayden Gephart, M., Plowey, E. D., & Barres, B. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.014 · Cited by 524 · see citing works
Kang, L., Yu, H., Yang, X., Zhu, Y., Bai, X., Wang, R., Cao, Y., Xu, H., Luo, H., Lu, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16191-y · Cited by 546 · see citing works
Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro
Chen, C. C., Liu, L., Ma, F., Wong, C. W., Guo, X. E., Chacko, J. V., Farhoodi, H. P., Zhang, S. X., Zimak, J., Ségaliny, A., et al. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0458-3 · Cited by 537 · see citing works
Immunomodulation by endothelial cells — partnering up with the immune system?
Amersfoort, J., Eelen, G., & Carmeliet, P. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00694-4 · Cited by 549 · see citing works
Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system.
Plog, B. A., Dashnaw, M. L., Hitomi, E., Peng, W., Liao, Y., Lou, N., Deane, R., & Nedergaard, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3742-14.2015 · Cited by 525 · see citing works
Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516 · see citing works
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet‐Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 524 · see citing works
Physiological blood–brain transport is impaired with age by a shift in transcytosis
Yang, A. C., Stevens, M. Y., Chen, M. B., Lee, D. P., Stähli, D., Gate, D., Contrepois, K., Chen, W., Iram, T., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2453-z · Cited by 477 · see citing works
Hersh, A. M., Alomari, S., & Tyler, B. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084153 · Cited by 478 · see citing works
Microbiome–microglia connections via the gut–brain axis
Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471 · see citing works
“This process of brain colonization precedes the formation of the BBB, which eventually shields microglia from potentially toxic peripheral influences throughout both fetal development and adulthood (Obermeier et al., 2013).”
BackgroundBiodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A. M., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 470 · see citing works
Microbiota-derived metabolites as drivers of gut–brain communication
Ahmed, H., Leyrolle, Q., Koistinen, V., Kärkkäinen, O., Layé, S., Delzenne, N., & Hanhineva, K. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2102878 · Cited by 462 · see citing works
Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
Oller‐Salvia, B., Sánchez‐Navarro, M., Giralt, E., & Teixidò, M. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00076b · Cited by 443 · see citing works
Yousef, H., Czupalla, C. J., Lee, D., Chen, M. B., Burke, A. N., Zera, K. A., Zandstra, J., Berber, E., Lehallier, B., Mathur, V., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0440-4 · Cited by 442 · see citing works
Neuronal regulation of the blood–brain barrier and neurovascular coupling
Kaplan, L., Chow, B. W., & Gu, C. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-0322-2 · Cited by 431 · see citing works
Mou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., Xiao, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.796288 · Cited by 432 · see citing works
Surface-Engineered Dendrimers in Gene Delivery
Jiepin, Y., Zhang, Q., Chang, H., & Cheng, Y. (2015) · Chemical Reviews · doi:10.1021/cr500542t · Cited by 432 · see citing works
Age-associated Physiological and Pathological Changes at the Blood-Brain Barrier: A Review
Erdő, F., Denes, L., & de Lange, E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16679420 · Cited by 426 · see citing works
The progress of gut microbiome research related to brain disorders
Zhu, S., Jiang, Y., Xu, K., Cui, M., Ye, W., Zhao, G., Jin, L., & Chen, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1705-z · Cited by 419 · see citing works
Mahmoudi, K., Bouras, A., Bozec, D., Ivkov, R., & Hadjipanayis, C. G. (2018) · International Journal of Hyperthermia · doi:10.1080/02656736.2018.1430867 · Cited by 417 · see citing works
Heye, A. K., Culling, R. D., Hernández, M. D. C. V., Thrippleton, M. J., & Wardlaw, J. M. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.09.002 · Cited by 408 · see citing works
YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation
Kim, J., Kim, Y. H., Kim, J., Park, D. Y., Bae, H., Lee, D. H., Kim, K. H., Hong, S. P., Jang, S. P., Kubota, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93825 · Cited by 402 · see citing works
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier
S. Hersh, D., S. Wadajkar, A., B. Roberts, N., G. Perez, J., P. Connolly, N., Frenkel, V., A. Winkles, J., F. Woodworth, G., & J. Kim, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151221150733 · Cited by 387 · see citing works
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Lange, C. M., Storkebaum, E., de Almodóvar, C. R., Dewerchin, M. A., & Carmeliet, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.88 · Cited by 374 · see citing works
The Molecular Constituents of the Blood–Brain Barrier
Chow, B. W., & Gu, C. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.003 · Cited by 374 · see citing works
Feng, L., Dou, C., Xia, Y., Li, B., Zhao, M., Yu, P., Zheng, Y., El‐Toni, A. M., Atta, N. F., Galal, A. M., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c07973 · Cited by 374 · see citing works
Wevers, N., Kasi, D. G., Gray, T., Wilschut, K., Smith, B. A., van Vught, R., Shimizu, F., Sano, Y., Kanda, T., Marsh, G., et al. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0108-3 · Cited by 325 · see citing works
Self-citationRetinal vasculature development in health and disease
Selvam, S., Kumar, T., & Fruttiger, M. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.11.001 · Cited by 357 · see citing works
Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity
Xu, B., Zhang, Y., Du, X.-F., Li, J., Zi, H.-X., Bu, J.-W., Yan, Y., Han, H., & Du, J.-L. (2017) · Cell Research · doi:10.1038/cr.2017.62 · Cited by 354 · see citing works
Canonical WNT signaling components in vascular development and barrier formation
Zhou, Y., Wang, Y., Tischfield, M. A., Williams, J., Smallwood, P. M., Rattner, A., Taketo, M. M., & Nathans, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76431 · Cited by 348 · see citing works
Ligand-installed nanocarriers toward precision therapy
Mi, P., Cabral, H., & Kataoka, K. (2020) · Advanced Materials · doi:10.1002/adma.201902604 · Cited by 350 · see citing works
Cefepime-induced neurotoxicity: a systematic review
Payne, L. E., Gagnon, D. J., Riker, R. R., Seder, D. B., Glisic, E. K., Morris, J. G., & Fraser, G. L. (2017) · Critical Care · doi:10.1186/s13054-017-1856-1 · Cited by 347 · see citing works
Shinozaki, Y., Shibata, K., Yoshida, K., Shigetomi, E., Gachet, C., Ikenaka, K., Tanaka, K. F., & Koizumi, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.047 · Cited by 341 · see citing works
Toxicity of Nanomaterials: Exposure, Pathways, Assessment, and Recent Advances
Ganguly, P., Breen, A., & Pillai, S. C. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00068 · Cited by 346 · see citing works
Inoue, Y., Shue, F., Bu, G., & Kanekiyo, T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00640-5 · Cited by 356 · see citing works
Coronary Microvascular Dysfunction
Vancheri, F., Longo, G., Vancheri, S., & Henein, M. Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092880 · Cited by 344 · see citing works
Toll-like receptors in the pathogenesis of neuroinflammation
Kumar, V. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.03.012 · Cited by 331 · see citing works
Focused ultrasound-mediated drug delivery through the blood–brain barrier
Burgess, A., Shah, K., Hough, O., & Hynynen, K. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1028369 · Cited by 325 · see citing works
Mechanisms of Blood–Brain Barrier Dysfunction in Traumatic Brain Injury
Cash, A., & Theus, M. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093344 · Cited by 324 · see citing works
Nanoparticles' interactions with vasculature in diseases
Tee, J. K., Yip, L. X., Tan, E. S., Santitewagun, S., Prasath, A., Ke, P. C., Ho, H. K., & Leong, D. T. (2019) · Chemical Society Reviews · doi:10.1039/c9cs00309f · Cited by 315 · see citing works
Xiao, X., Huang, S., Chen, S., Wang, Y., Sun, Q., Xu, X., & Li, Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02148-6 · Cited by 326 · see citing works
The blood–brain barrier in psychosis
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P. K., & Abbott, N. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30293-6 · Cited by 304 · see citing works
Factors controlling permeability of the blood–brain barrier
Almutairi, M. M., Chen, G., Xu, Y. G., Chang, Y., & Shi, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2050-8 · Cited by 308 · see citing works
Sun, Y., Koyama, Y., & Shimada, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903455 · Cited by 304 · see citing works
Gliomas and the vascular fragility of the blood brain barrier
Dubois, L. G., Campanati, L., Righy, C., Meira, I. D., Spohr, T. C. L. D. S. E., Porto-Carreiro, I., Pereira, C. M., Balça-Silva, J., Kahn, S. A., DosSantos, M. F. H., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00418 · Cited by 303 · see citing works
Bisht, K., Okojie, K. A., Sharma, K. P., Lentferink, D. H., Sun, Y., Chen, H., Uweru, J. O., Amancherla, S., Calcuttawala, Z., Campos-Salazar, A. B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25590-8 · Cited by 296 · see citing works
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
Cheng, Y., Desse, S., Martinez, A., Worthen, R. J., Jope, R. S., & Beurel, E. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.003 · Cited by 292 · see citing works
Blood-Brain Barrier Overview: Structural and Functional Correlation
Alahmari, A. (2021) · Neural Plasticity · doi:10.1155/2021/6564585 · Cited by 299 · see citing works
Pearn, M. L., Niesman, I. R., Egawa, J., Sawada, A., Almenar‐Queralt, A., Shah, S. B., Duckworth, J. L., & Head, B. P. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0400-1 · Cited by 298 · see citing works
Prakash, R., & Carmichael, S. T. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000248 · Cited by 296 · see citing works
The blood–tumour barrier in cancer biology and therapy
Steeg, P. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00529-6 · Cited by 294 · see citing works
Barrier function in the peripheral and central nervous system—a review
Reinhold, A., & Rittner, H. L. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1920-8 · Cited by 279 · see citing works
Exercise sustains the hallmarks of health
Qiu, Y., Fernández-García, B., Lehmann, H. I., Li, G., Kroemer, G., López-Otín, C., & Xiao, J. (2023) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2022.10.003 · Cited by 270 · see citing works
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy
Peng, X., Luo, Z., He, S., Zhang, L., & Li, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.768108 · Cited by 271 · see citing works
Zhou, Y., & Nathans, J. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.08.018 · Cited by 265 · see citing works
Bridging barriers: a comparative look at the blood–brain barrier across organismsPreprint
O’Brown, N. M., Pfau, S. J., & Gu, C. (2018) · Genes & Development · doi:10.1101/gad.309823.117 · Cited by 261 · see citing works
Cytokines and Chemokines in Cerebral Malaria Pathogenesis
Dunst, J., Kamena, F., & Matuschewski, K. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00324 · Cited by 264 · see citing works
Vanhollebeke, B., Stone, O. A., Bostaille, N., Cho, C., Zhou, Y., Maquet, E., Gauquier, A., Cabochette, P., Fukuhara, S., Mochizuki, N., et al. (2015) · eLife · doi:10.7554/elife.06489 · Cited by 260 · see citing works
Hussain, B., Fang, C., & Chang, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.688090 · Cited by 251 · see citing works
Neuronal and vascular interactions
Andreone, B. J., Lacoste, B., & Gu, C. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033835 · Cited by 256 · see citing works
Gpr124 is essential for blood–brain barrier integrity in central nervous system disease
Chang, J., Mancuso, M. R., Maier, C. M., Liang, X., Yuki, K., Yang, L., Kwong, J. W., Wang, J., Rao, V., Vallon, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4309 · Cited by 250 · see citing works
Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells
Qian, T., Maguire, S. E., Canfield, S. G., Bao, X., Olson, W. R., Shusta, E. V., & Palecek, S. P. (2017) · Science Advances · doi:10.1126/sciadv.1701679 · Cited by 254 · see citing works
MicroRNA-based therapeutics in central nervous system injuries
Sun, P., Liu, D., Jickling, G. C., Sharp, F. R., & Yin, K. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18773871 · Cited by 256 · see citing works
Niu, J., Tsai, H., Hoi, K. K., Huang, N., Yu, G., Kim, K., Baranzini, S. E., Xiao, L., Chan, J. R., & Fancy, S. P. J. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0369-4 · Cited by 241 · see citing works
Impacts of microbiome metabolites on immune regulation and autoimmunity
Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A. (2018) · Immunology · doi:10.1111/imm.12933 · Cited by 239 · see citing works
Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
Pediaditakis, I., Kodella, K. R., Manatakis, D., Le, C. Y., Hinojosa, C. D., Tien-Street, W., Manolakos, E., Vekrellis, K., Hamilton, G., Ewart, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-021-26066-5 · Cited by 174 · see citing works
Neurological issues in children with COVID-19
Lin, J. E., Asfour, A., Sewell, T. B., Hooe, B. S., Pryce, P. A., Earley, C., Shen, M. Y., Kerner-Rossi, M., Thakur, K. T., Vargas, W. S., et al. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135567 · Cited by 238 · see citing works
Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia
Greene, C., Kealy, J., Humphries, M. M., Gong, Y., Hou, J., Hudson, N., Cassidy, L. M., Martiniano, R., Shashi, V, Hooper, S. R., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.156 · Cited by 235 · see citing works
Löscher, W., & Friedman, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020591 · Cited by 235 · see citing works
Mei, B., Li, J., & Zuo, Z. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.10.008 · Cited by 234 · see citing works
Vatine, G. D., Al-Ahmad, A., Barriga, B. K., Svendsen, S., Salim, A., Garcia, L., Garcia, V. J., Ho, R., Yucer, N., Qian, T., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.04.002 · Cited by 233 · see citing works
No-reflow phenomenon in the heart and brain
Kloner, R. A., King, K. S., & Harrington, M. G. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00183.2018 · Cited by 231 · see citing works
Xu, M., Feng, T., Liu, B., Qiu, F., Xu, Y., Zhao, Y., & Zheng, Y. (2021) · Theranostics · doi:10.7150/thno.62330 · Cited by 229 · see citing works
- Authors
- Obermeier, B., Daneman, R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- University of California, San Francisco (US)
- Corresponding author
- Ransohoff, Richard M
- Venue
- Nature Medicine
- Published
- 2013-12
- Volume
- 19
- Issue
- 12
- Pages
- 1584-1596
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC4080800
- OpenAlex
- W1995037165
- Cited by
- 2,452
- References
- 180
- Citations by year
- 2026: 168 · 2025: 256 · 2024: 264 · 2023: 254 · 2022: 271 · 2021: 251 · 2020: 224 · 2019: 181 · 2018: 172 · 2017: 159 · 2016: 108 · 2015: 91 · 2014: 52
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R21NS074820, K24NS051400)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Cerebrospinal fluid and hydrocephalus
- Keywords
- blood-brain barrier, blood-brain barrier disruption, brain homeostasis, BBB repair, neuroinflammation, neurodegeneration, blood-brain barrier permeability, neurological disorders
- MeSH terms
- Animals, Blood Vessels, Blood-Brain Barrier, Brain, Humans, Nervous System Diseases, Neovascularization, Physiologic, Vascular Endothelial Growth Factor A, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review